Back
Inhibrx Biosciences 10K Form
Buy
54
INBX
Inhibrx Biosciences
Last Price:
14.08
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INBX News And Ratings
See the #1 stock for the next 7 days that we like better than INBX
INBX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.63M |
|---|---|
| Cash Flow: | $-30.53M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $12.33 |
| Price / Book: | 1.14 |
Profitability
| EPS (TTM): | 118.67400 |
|---|---|
| Net Income (TTM): | $1.76B |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Inhibrx Biosciences Earnings Forecast
Key Inhibrx Biosciences Financial Ratios
- The Research & Development expenses have been 7,964.08% of Revenue.
- The Net Earning history of INBX is -9,483.72% of Total Revenues.
- Per Share Earnings over the last 2 years have been positive in 0 years.
Inhibrx Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INBX |
| Website: | inhibrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INBX Technical Analysis vs Fundamental Analysis
Buy
54
Inhibrx Biosciences (INBX)
is a Buy
Is Inhibrx Biosciences a Buy or a Sell?
-
Inhibrx Biosciences stock is rated a Buy
The current Inhibrx Biosciences [INBX] share price is $14.08. The Score for INBX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.